Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics.
Gene Ther
; 28(6): 290-305, 2021 06.
Article
in English
| MEDLINE | ID: covidwho-977265
ABSTRACT
The novel coronavirus pneumonia (COVID-19) is a highly infectious acute respiratory disease caused by Severe Acute Respiratory Syndrome-Related Coronavirus (SARS-CoV-2) (Prec Clin Med 2020;39-13, Lancet 2020;395497-506, N. Engl J Med 2020a;3821199-207, Nature 2020;579270-3). SARS-CoV-2 surveillance is essential to controlling widespread transmission. However, there are several challenges associated with the diagnostic of the COVID-19 during the current outbreak (Liu and Li (2019), Nature 2020;579265-9, N. Engl J Med 2020;382727-33). Firstly, the high number of cases overwhelms diagnostic test capacity and proposes the need for a rapid solution for sample processing (Science 2018;360444-8). Secondly, SARS-CoV-2 is closely related to other important coronavirus species and subspecies, so detection assays can give false-positive results if they are not efficiently specific to SARS-CoV-2. Thirdly, patients with suspected SARS-CoV-2 infection sometimes have a different respiratory viral infection or co-infections with SARS-CoV-2 and other respiratory viruses (MedRxiv 2020a;1-18). Confirmation of the COVID-19 is performed mainly by virus isolation followed by RT-PCR and sequencing (N. Engl J Med 2020;382727-33, MedRxiv 2020a, Turkish J Biol 2020;44192-202). The emergence and outbreak of the novel coronavirus highlighted the urgent need for new therapeutic technologies that are fast, precise, stable, easy to manufacture, and target-specific for surveillance and treatment. Molecular biology tools that include gene-editing approaches such as CRISPR-Cas12/13-based SHERLOCK, DETECTR, CARVER and PAC-MAN, antisense oligonucleotides, antisense peptide nucleic acids, ribozymes, aptamers, and RNAi silencing approaches produced with cutting-edge scientific advances compared to conventional diagnostic or treatment methods could be vital in COVID-19 and other future outbreaks. Thus, in this review, we will discuss potent the molecular biology approaches that can revolutionize diagnostic of viral infections and therapies to fight COVID-19 in a highly specific, stable, and efficient way.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
RNA Interference
/
Gene Editing
/
COVID-19
Type of study:
Diagnostic study
Limits:
Humans
Language:
English
Journal:
Gene Ther
Journal subject:
Genetics, Medical
/
Therapeutics
Year:
2021
Document Type:
Article
Affiliation country:
S41434-020-00209-7
Similar
MEDLINE
...
LILACS
LIS